Gain Therapeutics Inc. (GANX)
NASDAQ · Healthcare
Gain Therapeutics Inc. Total Liabilities 2020–2023
Gain Therapeutics Inc. annual total liabilities history from 2020 to 2023. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Gain Therapeutics Inc. total liabilities as of December 31, 2023: 6.0M, a 15.54% increase year-over-year.
- Gain Therapeutics Inc. total liabilities for 2023 were 6.0M, a 15.54% increase from 2022.
- Gain Therapeutics Inc. total liabilities for 2022 were 5.2M, a 25.25% increase from 2021.
- Gain Therapeutics Inc. total liabilities for 2021 were 4.2M, a 22.49% increase from 2020.
- Gain Therapeutics Inc. total liabilities for 2020 were 3.4M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Gain Therapeutics Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2023 | $6 |
| 2022 | $5 |
| 2021 | $4 |
| 2020 | $3 |
Gain Therapeutics Inc. Total Liabilities — FAQ
Gain Therapeutics Inc. (GANX) total liabilities over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see GANX's total liabilities history?
The chart and table above show Gain Therapeutics Inc.'s total liabilities by year and by quarter, including the growth rate.